相似文献
1
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction.
Case Rep Psychiatry. 2014;2014:410403. doi: 10.1155/2014/410403. Epub 2014 Jul 17.
2
Topiramate-Related Hyperammonemia.
J Pharm Technol. 2016 Feb;32(1):34-36. doi: 10.1177/8755122515605849. Epub 2015 Sep 11.
3
Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature.
Respir Med Case Rep. 2018 May 30;25:1-3. doi: 10.1016/j.rmcr.2018.05.026. eCollection 2018.
4
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy.
Cureus. 2021 Dec 13;13(12):e20380. doi: 10.7759/cureus.20380. eCollection 2021 Dec.
5
Valproic acid-induced hyperammonemic encephalopathy - a potentially fatal adverse drug reaction.
Springerplus. 2013 Dec;2(1):13. doi: 10.1186/2193-1801-2-13. Epub 2013 Jan 15.
6
Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy.
Cureus. 2017 Aug 10;9(8):e1557. doi: 10.7759/cureus.1557.
7
Valproate-induced hyperammonemic encephalopathy: a case report.
J Med Case Rep. 2020 Jan 25;14(1):19. doi: 10.1186/s13256-020-2343-x.
8
Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
Clin Neuropharmacol. 2009 Nov-Dec;32(6):350-2. doi: 10.1097/WNF.0b013e3181ac3615.
9
Valproic Acid-Induced Hyperammonemic Encephalopathy in a Patient with Bipolar Disorder: A Case Report.
Brain Sci. 2020 Mar 24;10(3):187. doi: 10.3390/brainsci10030187.
10
[Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Rinsho Shinkeigaku. 2019 May 28;59(5):258-263. doi: 10.5692/clinicalneurol.cn-001254. Epub 2019 Apr 26.
引用本文的文献
1
What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?
Front Pharmacol. 2025 Jun 18;16:1477127. doi: 10.3389/fphar.2025.1477127. eCollection 2025.
2
Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.
BMJ Case Rep. 2023 Nov 30;16(11):e256796. doi: 10.1136/bcr-2023-256796.
3
Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases.
JIMD Rep. 2020 Jun 11;55(1):3-11. doi: 10.1002/jmd2.12131. eCollection 2020 Sep.
4
Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.
Cureus. 2018 Sep 12;10(9):e3292. doi: 10.7759/cureus.3292.
5
Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review.
Ment Health Clin. 2018 Apr 26;8(3):148-154. doi: 10.9740/mhc.2018.05.148. eCollection 2018 May.
6
Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.
Rev Endocr Metab Disord. 2018 Mar;19(1):69-79. doi: 10.1007/s11154-018-9444-5.
7
Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
Psychopharmacol Bull. 2017 Jan 26;47(1):40-44.
8
Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient.
Case Rep Psychiatry. 2016;2016:6242314. doi: 10.1155/2016/6242314. Epub 2016 Jul 19.
9
Valproate Induced Delirium due to Hyperammonemia in a Case of Acute Mania: A Diagnostic Dilemma.
J Clin Diagn Res. 2015 Apr;9(4):VD01-VD02. doi: 10.7860/JCDR/2015/11830.5758. Epub 2015 Apr 1.
本文引用的文献
1
Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
Gen Hosp Psychiatry. 2012 May-Jun;34(3):290-8. doi: 10.1016/j.genhosppsych.2011.12.009. Epub 2012 Feb 2.
2
Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
Clin Neuropharmacol. 2009 Nov-Dec;32(6):350-2. doi: 10.1097/WNF.0b013e3181ac3615.
3
Valproate-associated hyperammonemic encephalopathy.
J Am Board Fam Med. 2007 Sep-Oct;20(5):499-502. doi: 10.3122/jabfm.2007.05.070062.
4
Hyperammonemia due to valproic acid in the psychiatric setting.
Am J Psychiatry. 2007 Jul;164(7):1020-7. doi: 10.1176/ajp.2007.164.7.1020.
5
Valproate-induced hyperammonemic encephalopathy.
Acta Neurol Scand. 2006 Jul;114(1):1-7. doi: 10.1111/j.1600-0404.2006.00655.x.
6
Valproate-induced hyperammonemic encephalopathy.
Metab Brain Dis. 2002 Dec;17(4):367-73. doi: 10.1023/a:1021918104127.
7
Valproate-induced hyperammonaemia.
J Clin Psychopharmacol. 2002 Dec;22(6):631-3. doi: 10.1097/00004714-200212000-00019.
8
Practice guideline for the treatment of patients with bipolar disorder (revision).
Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50.
9
The role of carnitine supplementation during valproic acid therapy.
Ann Pharmacother. 2000 May;34(5):630-8. doi: 10.1345/aph.19242.
10
Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
Neurology. 2000 Jan 11;54(1):230-2. doi: 10.1212/wnl.54.1.230.
Zotero 插件